Vor Biopharma Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $46.2M | $142.9M | $81.9M |
| FY2025 | $628.4M | $464.1M | $396.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2024 | $46.2M | $142.9M | $81.9M |
| FY2025 | $628.4M | $464.1M | $396.5M |